On December 5, 2025, a panel from the Centers for Disease Control and Prevention (CDC) voted 8-3 to discontinue the recommendation that all infants receive the hepatitis B vaccine at birth. This decision marks a significant change in the CDC"s vaccination policy for newborns.
The panel"s vote reflects ongoing discussions about vaccination protocols and public health recommendations. The hepatitis B vaccine has been a standard part of infant immunization schedules for many years, aimed at preventing the transmission of the virus that can lead to serious liver disease.
For more information on related health policies, see Germany"s parliament mandates military medical screening for all males at 18.
This recent decision by the CDC panel may influence future discussions regarding vaccination practices and public health strategies in the United States.
Image for CDC vaccine panel votes 8-3 to end hepatitis B vaccine recommendation for infants
